Talbot JN - Search Results

1

[Sentinel lymph node biopsy in breast cancer: feasibility study and initial experiments].

Barranger E, Grahek D, Antoine M, Benchimol Y, Talbot JN, Uzan S. Barranger E, et al. Among authors: talbot jn. Gynecol Obstet Fertil. 2002 Jun;30(6):492-7. doi: 10.1016/s1297-9589(02)00358-2. Gynecol Obstet Fertil. 2002. PMID: 12146150 French.

2

Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma.

Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Barranger E, et al. Among authors: talbot jn. Cancer. 2003 Jun 15;97(12):3003-9. doi: 10.1002/cncr.11423. Cancer. 2003. PMID: 12784335 Free article.

3

Contralateral axillary sentinel lymph node drainage in breast cancer: a case report.

Barranger E, Montravers F, Kerrou K, Marpeau O, Raileanu I, Antoine M, Talbot JN, Uzan S. Barranger E, et al. Among authors: talbot jn. J Surg Oncol. 2004 Jun 1;86(3):167-9. doi: 10.1002/jso.20056. J Surg Oncol. 2004. PMID: 15170657

4

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.

Barranger E, Grahek D, Antoine M, Montravers F, Talbot JN, Uzan S. Barranger E, et al. Among authors: talbot jn. Ann Surg Oncol. 2003 Jul;10(6):622-7. doi: 10.1245/aso.2003.12.019. Ann Surg Oncol. 2003. PMID: 12839846 Clinical Trial.

5

[Sentinel lymph node biopsy in breast cancer: technical aspects and results].

Barranger E, Grahek D, Antoine M, Talbot JN, Uzan S. Barranger E, et al. Among authors: talbot jn. Ann Chir. 2003 Apr;128(3):144-9. doi: 10.1016/s0003-3944(03)00039-7. Ann Chir. 2003. PMID: 12821079 Review. French.

6

CA 15-3 and bone scintigraphy in the follow-up of breast cancer.

Younsi N, Montravers F, Philippe C, Seddiki M, Uzan S, Izrael V, Talbot JN. Younsi N, et al. Among authors: talbot jn. Int J Biol Markers. 1997 Oct-Dec;12(4):154-7. doi: 10.1177/172460089701200403. Int J Biol Markers. 1997. PMID: 9582604 Review.

7

[(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].

Talbot JN, Grahek D, Kerrou K, Younsi N, de Beco V, Colombet-Lamau C, Petegnief Y, Cailleux N, Montravers F. Talbot JN, et al. Gynecol Obstet Fertil. 2001 Nov;29(11):775-98. doi: 10.1016/s1297-9589(01)00197-7. Gynecol Obstet Fertil. 2001. PMID: 11770272 Review. French.

8

[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].

Grahek D, Montravers F, Mayaud C, Regnard JF, Kerrou K, Younsi N, Talbot JN. Grahek D, et al. Among authors: talbot jn. Rev Pneumol Clin. 2001 Dec;57(6):393-403. Rev Pneumol Clin. 2001. PMID: 11924148 Review. French.

9

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.

Grahek D, Montravers F, Kerrou K, Aide N, Lotz JP, Talbot JN. Grahek D, et al. Among authors: talbot jn. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):179-88. doi: 10.1007/s00259-003-1348-1. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129699 Clinical Trial.

10

Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.

Montravers F, Younsi N, Rousseau C, Philippe C, Seddiki M, Uzan S, Izrael V, Talbot JN. Montravers F, et al. Among authors: talbot jn. Anticancer Res. 1997 May-Jun;17(3B):1683-6. Anticancer Res. 1997. PMID: 9179218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters